Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;76(1):64-75.
doi: 10.1111/his.14008.

Uterine mesenchymal tumours: recent advances

Amir Momeni-Boroujeni  1 , Sarah Chiang  1
Affiliations
Review

Uterine mesenchymal tumours: recent advances

Amir Momeni-Boroujeni et al. Histopathology. 2020 Jan.

Abstract

Almost all uterine mesenchymal tumours have been historically classified as either smooth muscle or endometrial stromal neoplasms. Recent application of molecular techniques has identified numerous lesions with distinctive genetic abnormalities and clinicopathological characteristics. Newly discovered uterine sarcoma subtypes include high-grade endometrial stromal sarcomas with BCOR genetic abnormalities, fibrosarcoma-like uterine sarcomas with NTRK rearrangements and COL1A-PDGFRB fusions, as well as undifferentiated uterine sarcomas with SMARCA4 mutations. Novel PLAG1 and PGR fusions have been identified in subsets of myxoid and epithelioid leiomyosarcomas. Some uterine tumours resembling ovarian sex-cord tumour harbour GREB1 and ESR1 rearrangements. Histological and immunophenotypical features as well as underlying genetic abnormalities defining these lesions are discussed.

Keywords: endometrial stromal sarcoma; epithelioid leiomyosarcoma; fibrosarcoma; myxoid leiomyosarcoma; undifferentiated uterine sarcoma; uterine tumour resembling ovarian sex cord tumour.

PubMed Disclaimer

References

    1. Fan Z, Yamaza T, Lee JS et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat. Cell Biol. 2009; 11; 1002-1009.
    1. Lewis N, Soslow RA, Delair DF et al. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod. Pathol. 2018; 31; 674-684.
    1. Hoang LN, Aneja A, Conlon N et al. Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma. Am. J. Surg. Pathol. 2017; 41; 12-24.
    1. Marino-Enriquez A, Lauria A, Przybyl J et al. BCOR internal tandem duplication in high-grade uterine sarcomas. Am. J. Surg. Pathol. 2018; 42; 335-341.
    1. Chiang S, Lee CH, Stewart CJR et al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod. Pathol. 2017; 30; 1251-1261.